Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Bryan T. Butman"'
Autor:
John G. Neilan, Christopher Schutta, José Barrera, Melia Pisano, Laszlo Zsak, Ethan Hartwig, Max V. Rasmussen, Barbara J. Kamicker, Damodar Ettyreddy, Douglas E. Brough, Bryan T. Butman, David A. Brake
Publikováno v:
BMC Veterinary Research, Vol 14, Iss 1, Pp 1-9 (2018)
Abstract Background A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized w
Externí odkaz:
https://doaj.org/article/d44e40a861c547708a6f63307b3c82ea
Autor:
Max V. Rasmussen, William Hurtle, Mariceny Zurita, Damodar Ettyreddy, Christopher Schutta, Bruce G. Harper, David A. Brake, Barbara J. Kamicker, Melia Pisano, Douglas E. Brough, John G. Neilan, Bryan T. Butman, Carla Bravo de Rueda, José Barrera
Publikováno v:
Vaccine. 36:7345-7352
We investigated the serotype- and topotype versatility of a replication-deficient human adenovirus serotype 5 vectored foot-and-mouth disease (FMD) vaccine platform (AdtFMD). Sixteen AdtFMD recombinant subunit monovalent vaccines targeting twelve dis
Autor:
John G. Neilan, Barbara J. Kamicker, Michelle M. Colby, David A. Brake, K. Lechtenberg, José Barrera, R. Kaptur, T. Schieber, D. E. Brough, Bryan T. Butman, T. D. Miller, Damodar Ettyreddy, C. Purcell
Publikováno v:
Transboundary and Emerging Diseases. 65:447-455
The safety of a replication-deficient, human adenovirus-vectored foot-and-mouth disease virus (FMDV) serotype A24 Cruzeiro capsid-based subunit vaccine (AdtA24) was evaluated in five independent safety studies. The target animal safety studies were d
Autor:
Barbara J. Kamicker, Gregory A. Mayr, David A. Brake, Mauro P. Moraes, Laszlo Zsak, Damodar Ettyreddy, Christopher Schutta, Douglas E. Brough, Marvin J. Grubman, Bryan T. Butman, Melia Pisano, John G. Neilan, José Barrera
Publikováno v:
Vaccine. 34:3214-3220
The safety and efficacy of an experimental, replication-deficient, human adenovirus-vectored foot-and-mouth disease virus (FMDV) serotype A24 Cruzeiro capsid-based subunit vaccine (AdtA24) was examined in eight independent cattle studies. AdtA24 non-
Autor:
Barbara J. Kamicker, David A. Brake, José Barrera, Ethan J. Hartwig, Max V. Rasmussen, Douglas E. Brough, John G. Neilan, Laszlo Zsak, Bryan T. Butman, Melia Pisano, Damodar Ettyreddy, Christopher Schutta
Publikováno v:
BMC Veterinary Research
BMC Veterinary Research, Vol 14, Iss 1, Pp 1-9 (2018)
BMC Veterinary Research, Vol 14, Iss 1, Pp 1-9 (2018)
Background A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a rep
Autor:
Douglas E. Brough, Marvin J. Grubman, John G. Neilan, Bryan T. Butman, José Barrera, Barbara J. Kamicker, David A. Brake, Melia Pisano, Damodar Ettyreddy, Christopher Schutta, Femi Olutunmbi, Timothy J. Miller
Publikováno v:
Vaccine. 36(8)
A foot-and-mouth disease (FMD) recombinant subunit vaccine formulated with a lipid/polymer adjuvant was evaluated in two vaccine efficacy challenge studies in steers. The vaccine active ingredient is a replication-deficient human adenovirus serotype
Autor:
John G. Neilan, Marvin J. Grubman, Bryan T. Butman, Douglas E. Brough, José Barrera, Mauro P. Moraes, Damodar Ettyreddy, Christopher Schutta, David A. Brake
Publikováno v:
Future Virology. 5:51-64
The results of the first decade of the development of a replication-defective human adenovirus serotype 5 (Ad5) containing the capsid- and 3C protease-coding regions of foot-and-mouth disease (FMD) virus as a vaccine candidate are presented. In proof
Autor:
Bryan T. Butman, Douglas E. Brough, Rebecca L. Sheets, Phil Gomez, Jason G. Gall, Alena Lizonova, Perry Newton, J. Sowers, Victoria Haque
Publikováno v:
BioProcessing Journal. 5:15-19
Autor:
Eddie P. Jeffries, Christine Shen, Robert G. Lahita, Barry L. Myones, Bryan T. Butman, Hong Wei Zhang, Joan T. Merrill
Publikováno v:
Thrombosis and Haemostasis. 81:748-757
SummaryThrombosis in the antiphospholipid syndrome has been associated with acquired deficiency of the anticoagulant protein S. We sought evidence that β2-glycoprotein I, a major target antigen for antiphospholipid antibodies, is involved in regulat
Autor:
Janet H. Ransom, Joachim Greilberger, Bryan T. Butman, Walter Petek, Paul F. Macomber, Peter Költringer, Günther Jürgens, Wendy C. Taddei-Peters, Qi Chen, Andrew G. Stead
Publikováno v:
Stroke. 26:1841-1848
Background and Purpose Serum lipoprotein(a) [Lp(a)] levels are genetically determined and considered to be an independent risk factor for atherosclerosis. The aim of this study was to provide a complete analysis of Lp(a) serum levels, apolipoprotein(